Two major studies have unveiled promising new tools for tackling Alzheimer’s disease: Johns Hopkins researchers used lab-grown brain organoids to test patient-specific drug responses and identify ...
A new study shows that a common blood test ratio involving immune cells, the neutrophil-to-lymphocyte ratio, may indicate elevated Alzheimer’s and dementia risk years before symptoms appear. The ...